Glen Burkhardt - May 20, 2022 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
SVP of Human Resources
Signature
/s/ John P. Sharp, Attorney-in-fact
Stock symbol
PHASQ
Transactions as of
May 20, 2022
Transactions value $
-$1,223
Form type
4
Date filed
5/24/2022, 05:14 PM
Previous filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Award $7.66K +11.2K $0.68* 11.2K May 20, 2022 Direct F1, F2
transaction PHASQ Common Stock Sale -$8.89K -11.2K -100% $0.79* 0 May 23, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") in a transaction that is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
F2 In accordance with the ESPP provisions, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 20, 2022.
F3 The shares reported were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.